← All stocks

CG Oncology, Inc.

CGON Net buying

CIK 0001991792 #1141 in the set updated 17 Sep 2026

Bought (120 mo)

$87.48M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$53.15M

$2.78M on a plan · $7.77M straight out of an exercise

Sold at will

$42.60M

3 of 42 sales

Net

+$34.33M

+$44.88M against sales at will

By person

8 insiders · 50 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Liu Brian Guan-Chyun

Director

$74.81M (2)

—

+$74.81M

1,886,236

2.13%

$140.60M

—

Song Hong Fang

Director

$5.00M (1)

$45.38M (7)

−$40.38M

3,517,859

3.97%

$262.22M

—

Decheng Capital Global Life Sciences Fund IV, L.P. entity

10% owner

$7.60M (1)

—

+$7.60M

4,958,812

5.59%

$369.63M

+432.9%

Mulay James

Director

—

$6.28M (16) scheduled

−$6.28M

0.0000%

$0.00

—

POST LEONARD E

Director

—

$1.49M (19) scheduled

−$1.49M

0.0000%

$0.00

—

Roche Corleen M.

CFO

$38.00K (1)

—

+$38.00K

2,000

0.0023%

$149.08K

—

Kasturi Vijay

Chief Medical Officer

$24.99K (1)

—

+$24.99K

1,315

0.0015%

$98.02K

—

Kuan Arthur

Chief Executive Officer

—

198,916

0.2244%

$14.83M

+450.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Kuan Arthur

12 Mar 2026

Chief Executive Officer

Exercised, kept

64,612

$1.72

$111.13K

Kuan Arthur

4 Mar 2026

Chief Executive Officer

Exercised, kept

102,871

$1.72

$176.94K

Show all 50 transactions →

What was left out

Form 4 filings counted 73

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 35

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 9,246,735

History held since 26 Jan 2024